<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04307524</url>
  </required_header>
  <id_info>
    <org_study_id>cesarean scar niche</org_study_id>
    <nct_id>NCT04307524</nct_id>
  </id_info>
  <brief_title>Laparoscopic Repair of Cesarean Scar Niche</brief_title>
  <official_title>Laparoscopic Repair Of Cesarean Scar Niche: Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zagazig University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zagazig University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of laparoscopy repair of cesarean scar niche in resolution of symptoms related to&#xD;
      niche as compared to expectant management.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Recently, The percentage of Cesarean section (CS) deliveries has dramatically increased in&#xD;
      most countries. The presence of a niche at the site of a CS scar has been observed. A niche&#xD;
      is mainly a sonographic finding defined as a triangular anechoic area at site of incision. (&#xD;
      Mascarello et al, 2017) Alternative terms for a niche are Cesarean scar defect (Wang et al,&#xD;
      2009), deficient Cesarean scar (Ofili-Yebovi et al, 2008), diverticulum (Surapaneni et al,&#xD;
      2008), pouch (Fabres el al, 2003) and isthmocele. (bogres el al, 2010) As not all women with&#xD;
      previous CS develop a niche, it is a matter of interest to identify the risk factors that may&#xD;
      predict their development. (Sholapurkar , 2018) Possible causes of this condition may be&#xD;
      surgery or patient related. Surgery related factors as low cervical incision, incomplete&#xD;
      closure of the uterus (decidual sparing) and inadequate hemostasis. Patient related factors&#xD;
      may be attributed to infection. ( Vervoort et al, 2015) Cesarean scar niche may be&#xD;
      asymptomatic or may cause a number of obstetrical and gynecological problems (cesarean scar&#xD;
      syndrome) . ( Vervoort et al,2015b) Obstetrical complications of the niche are cesarean scar&#xD;
      ectopic pregnancy, placenta previa and morbidly adherent placenta, cesarean scar dehiscence&#xD;
      following incomplete abortion secondary to uterotonic drugs, Scar dehiscence and tender scar&#xD;
      even scar rupture (Tanimura el al, 2015) Gynecological symptoms of the niche are&#xD;
      postmenstrual spotting, Intermenstrual bleeding, Dysmenorrheal, Dysparunia and secondary&#xD;
      infertility. (Tanimura el al, 2015) Various methods to detect and measure a niche have been&#xD;
      described. The majority of papers have evaluated the niche with the use of transvaginal&#xD;
      sonography (TVS) (Vaate et al, 2011), and contrast-enhanced sonohysterography (SHG) (Bij de&#xD;
      Vaate et al, 2011), but a minority have used hysteroscopy (El-Mazny et al, 2011) or&#xD;
      hysterosalpingography. (Surapaneni and Silberzweig, 2008 ) At present there is no consensus&#xD;
      regarding the gold standard for the detection and measurement of a niche. (Vaate et al, 2014)&#xD;
      Symptomatic cesarean scar niche (cesarean scar syndrome) can be managed conservatively using&#xD;
      combined oral contraceptive pills especially in women not seeking fertility, or it can be&#xD;
      treated using minimal invasive surgery as hysteroscopic resection (vervoot et al,2017) ,&#xD;
      laparoscopic repair (ma et al,2017) or vaginal repair (Yao, 2014) In this study we will&#xD;
      evaluate laparoscopic management of cesarean scar niche&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 15, 2020</start_date>
  <completion_date type="Anticipated">March 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 15, 2021</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>randomized controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>computer-generated sequence</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>post-menstrual spotting</measure>
    <time_frame>6 month after intervention</time_frame>
    <description>number of days of post-menstrual spotting &quot;spotting or bleeding after 8 days of menstruation whatever the amount</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>menstrual related pain</measure>
    <time_frame>6 month after intervention</time_frame>
    <description>degree of menstrual related pain as descriped by the patient on Visual Analogue Scale of pain from 1 to 10</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>infertility</measure>
    <time_frame>6 month after intervention</time_frame>
    <description>failure of conception despite regular sexual intercourse within 6 months from intervention or stopping gynera</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Cesarean Section Complications</condition>
  <arm_group>
    <arm_group_label>laparoscopic repair</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>suture repair of cesarean scar niche using laparoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>medical treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>conservative management</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>laparoscopic repair</intervention_name>
    <description>laparoscopic suture repair of cesarean scar niche</description>
    <arm_group_label>laparoscopic repair</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>medical treatment in the form of combined hormonal contraception</intervention_name>
    <description>patient will receive for three months daily without interruption, no pill-free interval drug names is &quot;Genera&quot; BAYERhealthcare</description>
    <arm_group_label>medical treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. History of cesarean section.&#xD;
&#xD;
          2. Postmenstrual and/or intermenstrual spotting.&#xD;
&#xD;
          3. Cesarean scar niche of at least 2 mm in depth diagnosed by saline infusion sonography&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. pregnancy&#xD;
&#xD;
          2. Uterine anomalies&#xD;
&#xD;
          3. Hysterotomy.&#xD;
&#xD;
          4. history Placenta previa and MAP&#xD;
&#xD;
          5. Upper segment incision, Vertical uterine incision&#xD;
&#xD;
          6. submucosal fibroids&#xD;
&#xD;
          7. adenomyosis.&#xD;
&#xD;
          8. History atypical endometrial cells, cervical dysplasia,&#xD;
&#xD;
          9. cervical or pelvic infection.&#xD;
&#xD;
         10. Irregular cycle.&#xD;
&#xD;
         11. lactation amenorrhea.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>February 21, 2020</study_first_submitted>
  <study_first_submitted_qc>March 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 13, 2020</study_first_posted>
  <last_update_submitted>March 11, 2020</last_update_submitted>
  <last_update_submitted_qc>March 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zagazig University</investigator_affiliation>
    <investigator_full_name>Mahmoud Ismail Abdel Rahman Kotb</investigator_full_name>
    <investigator_title>Specialist &amp; Assistant Lecturer of obstetrics and gynecology</investigator_title>
  </responsible_party>
  <keyword>cesarean scar niche</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

